Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Vectors | 15 | 2004 | 927 | 1.010 |
Why?
|
| Liver | 18 | 2000 | 1806 | 0.980 |
Why?
|
| Visual Cortex | 5 | 2025 | 132 | 0.810 |
Why?
|
| Retroviridae | 11 | 2004 | 194 | 0.660 |
Why?
|
| Genetic Therapy | 13 | 2004 | 720 | 0.530 |
Why?
|
| Promoter Regions, Genetic | 10 | 1998 | 1294 | 0.520 |
Why?
|
| alpha 1-Antitrypsin | 10 | 1997 | 83 | 0.480 |
Why?
|
| Hepatocyte Growth Factor | 3 | 2000 | 37 | 0.350 |
Why?
|
| Transfection | 6 | 1996 | 999 | 0.310 |
Why?
|
| Transduction, Genetic | 5 | 1999 | 294 | 0.300 |
Why?
|
| Moloney murine leukemia virus | 4 | 1996 | 18 | 0.270 |
Why?
|
| Models, Neurological | 2 | 2025 | 218 | 0.260 |
Why?
|
| Connectome | 2 | 2025 | 122 | 0.250 |
Why?
|
| Mucopolysaccharidosis VII | 2 | 2004 | 3 | 0.230 |
Why?
|
| Glucuronidase | 2 | 2004 | 30 | 0.220 |
Why?
|
| Color Vision | 1 | 2024 | 11 | 0.220 |
Why?
|
| beta-Galactosidase | 3 | 1996 | 139 | 0.220 |
Why?
|
| Spleen | 3 | 2000 | 272 | 0.200 |
Why?
|
| Photic Stimulation | 4 | 2025 | 235 | 0.200 |
Why?
|
| Gene Expression Regulation | 5 | 1999 | 2444 | 0.200 |
Why?
|
| Neurons | 4 | 2025 | 2016 | 0.200 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 1996 | 357 | 0.190 |
Why?
|
| Color | 1 | 2022 | 35 | 0.190 |
Why?
|
| Reflex, Pupillary | 1 | 2022 | 16 | 0.190 |
Why?
|
| Rats | 12 | 1999 | 3612 | 0.190 |
Why?
|
| Pupil | 1 | 2022 | 56 | 0.190 |
Why?
|
| Vision, Ocular | 1 | 2022 | 133 | 0.180 |
Why?
|
| Animals | 25 | 2025 | 34953 | 0.170 |
Why?
|
| Mice | 15 | 2025 | 18566 | 0.170 |
Why?
|
| Lysosomes | 2 | 2004 | 261 | 0.160 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 111 | 0.160 |
Why?
|
| Protein C | 1 | 1998 | 17 | 0.150 |
Why?
|
| Lipopolysaccharides | 1 | 1999 | 306 | 0.140 |
Why?
|
| Factor X Deficiency | 1 | 1997 | 1 | 0.130 |
Why?
|
| Factor X | 1 | 1997 | 4 | 0.130 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1996 | 59 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 350 | 0.130 |
Why?
|
| Genes, ras | 1 | 1996 | 100 | 0.130 |
Why?
|
| Cyclins | 1 | 1996 | 100 | 0.120 |
Why?
|
| Adenoviridae | 1 | 1999 | 596 | 0.120 |
Why?
|
| ras Proteins | 1 | 1996 | 146 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 1996 | 201 | 0.120 |
Why?
|
| Base Sequence | 5 | 2000 | 2902 | 0.110 |
Why?
|
| Liver Regeneration | 4 | 1999 | 41 | 0.110 |
Why?
|
| Cell Division | 3 | 2000 | 744 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 761 | 0.110 |
Why?
|
| Dendrites | 2 | 2025 | 204 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 4764 | 0.100 |
Why?
|
| Animals, Newborn | 2 | 2004 | 1034 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1994 | 493 | 0.090 |
Why?
|
| Gene Expression | 3 | 1994 | 1564 | 0.090 |
Why?
|
| Hepatectomy | 4 | 1996 | 124 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 1994 | 701 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 3778 | 0.080 |
Why?
|
| Liposomes | 1 | 1991 | 203 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 5 | 1999 | 1225 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 1994 | 1132 | 0.070 |
Why?
|
| Acute-Phase Proteins | 2 | 1999 | 45 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 1996 | 3061 | 0.070 |
Why?
|
| 3T3 Cells | 2 | 1997 | 124 | 0.060 |
Why?
|
| RNA Polymerase II | 3 | 1996 | 87 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 1997 | 2679 | 0.060 |
Why?
|
| Male | 10 | 2025 | 64918 | 0.060 |
Why?
|
| Color Perception | 1 | 2024 | 12 | 0.060 |
Why?
|
| Orientation | 1 | 2024 | 47 | 0.050 |
Why?
|
| Primates | 1 | 2024 | 85 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1996 | 293 | 0.050 |
Why?
|
| Liver Transplantation | 3 | 1992 | 1104 | 0.050 |
Why?
|
| Visual Pathways | 1 | 2024 | 85 | 0.050 |
Why?
|
| Visual Fields | 1 | 2024 | 145 | 0.050 |
Why?
|
| Darkness | 1 | 2022 | 26 | 0.050 |
Why?
|
| DNA | 2 | 1999 | 1483 | 0.050 |
Why?
|
| Binding Sites | 2 | 1996 | 1256 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 1994 | 258 | 0.050 |
Why?
|
| Axons | 1 | 2025 | 394 | 0.050 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2022 | 89 | 0.050 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2022 | 78 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2022 | 202 | 0.050 |
Why?
|
| Synapses | 1 | 2025 | 461 | 0.040 |
Why?
|
| Dogs | 4 | 2004 | 651 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 1999 | 1997 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 87 | 0.040 |
Why?
|
| Cell Movement | 2 | 1995 | 891 | 0.040 |
Why?
|
| DNA Primers | 1 | 2000 | 637 | 0.040 |
Why?
|
| Drug Synergism | 1 | 1999 | 234 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 109 | 0.040 |
Why?
|
| Bromodeoxyuridine | 1 | 1999 | 57 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 1999 | 196 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 200 | 0.040 |
Why?
|
| Rats, Inbred Lew | 1 | 1998 | 70 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 1999 | 263 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 1999 | 232 | 0.030 |
Why?
|
| Serum Albumin | 2 | 1994 | 113 | 0.030 |
Why?
|
| Humans | 13 | 2000 | 132105 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 1995 | 2453 | 0.030 |
Why?
|
| NF-kappa B | 1 | 1999 | 454 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 1996 | 16 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 1996 | 18 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 97 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1996 | 86 | 0.030 |
Why?
|
| Portal Vein | 1 | 1996 | 90 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 1996 | 162 | 0.030 |
Why?
|
| Carcinogens | 1 | 1996 | 129 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1997 | 454 | 0.030 |
Why?
|
| Toxins, Biological | 1 | 1996 | 72 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1997 | 413 | 0.030 |
Why?
|
| Trans-Activators | 1 | 1999 | 714 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1996 | 253 | 0.030 |
Why?
|
| Phosphorylation | 1 | 1999 | 1613 | 0.030 |
Why?
|
| Albumins | 1 | 1996 | 95 | 0.030 |
Why?
|
| Galactosides | 1 | 1995 | 11 | 0.030 |
Why?
|
| Fluoresceins | 1 | 1995 | 33 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 89 | 0.030 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 1994 | 2 | 0.030 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 1994 | 9 | 0.030 |
Why?
|
| Methylation | 1 | 1995 | 216 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1994 | 42 | 0.030 |
Why?
|
| Cell Separation | 1 | 1995 | 227 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 1994 | 33 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1996 | 491 | 0.030 |
Why?
|
| Proviruses | 1 | 1994 | 18 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 1047 | 0.030 |
Why?
|
| Indoles | 1 | 1995 | 201 | 0.030 |
Why?
|
| Gene Dosage | 1 | 1995 | 449 | 0.030 |
Why?
|
| RNA, Viral | 1 | 1996 | 565 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1994 | 365 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1995 | 806 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 1723 | 0.020 |
Why?
|
| Biopsy | 1 | 1996 | 1290 | 0.020 |
Why?
|
| Female | 3 | 2025 | 70680 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1994 | 357 | 0.020 |
Why?
|
| Time Factors | 1 | 2022 | 6445 | 0.020 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 1992 | 37 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2004 | 2059 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1996 | 877 | 0.020 |
Why?
|
| Tissue Transplantation | 1 | 1991 | 11 | 0.020 |
Why?
|
| Transplantation, Heterotopic | 1 | 1991 | 27 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1991 | 92 | 0.020 |
Why?
|
| Splenectomy | 1 | 1991 | 62 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 181 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 341 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1991 | 132 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1994 | 1554 | 0.020 |
Why?
|
| Apoptosis | 1 | 1996 | 1904 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1994 | 1050 | 0.020 |
Why?
|
| Transcription Factors | 2 | 1996 | 2494 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1996 | 2064 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 1351 | 0.020 |
Why?
|
| Signal Transduction | 1 | 1999 | 4725 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1996 | 991 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1991 | 1425 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1991 | 995 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 1396 | 0.010 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2004 | 10 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2004 | 34 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 246 | 0.010 |
Why?
|
| Dog Diseases | 1 | 2004 | 59 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2004 | 241 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 178 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2004 | 270 | 0.010 |
Why?
|
| Aortic Valve | 1 | 2004 | 485 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 554 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2004 | 989 | 0.010 |
Why?
|
| Myocardium | 1 | 2004 | 908 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 652 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 1994 | 44 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 4694 | 0.010 |
Why?
|
| Retroviridae Proteins | 1 | 1992 | 11 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1992 | 285 | 0.010 |
Why?
|
| Forecasting | 1 | 1992 | 372 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1992 | 441 | 0.010 |
Why?
|
| Cell Survival | 1 | 1992 | 869 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 1285 | 0.000 |
Why?
|
| Models, Biological | 1 | 1992 | 1441 | 0.000 |
Why?
|
| Phenotype | 1 | 1992 | 4541 | 0.000 |
Why?
|